Found: 16
Select item for more details and to access through your institution.
Isoniazid Adherence Reduces Mortality and Incident Tuberculosis at 96 Weeks Among Adults Initiating Antiretroviral Therapy With Advanced Human Immunodeficiency Virus in Multiple High-Burden Settings.
- Published in:
- Open Forum Infectious Diseases, 2022, v. 9, n. 7, p. 1, doi. 10.1093/ofid/ofac325
- By:
- Publication type:
- Article
Third‐line antiretroviral therapy, including raltegravir (RAL), darunavir (DRV/r) and/or etravirine (ETR), is well tolerated and achieves durable virologic suppression over 144 weeks in resource‐limited settings: ACTG A5288 strategy trial.
- Published in:
- Journal of the International AIDS Society, 2022, v. 25, n. 6, p. 1, doi. 10.1002/jia2.25905
- By:
- Publication type:
- Article
Predictors of virologic outcome among people living with HIV who continue a protease inhibitor-based antiretroviral regimen following virologic failure with no or limited resistance.
- Published in:
- AIDS Research & Therapy, 2023, v. 20, n. 1, p. 1, doi. 10.1186/s12981-022-00494-9
- By:
- Publication type:
- Article
Impact of Larger Sputum Volume on Xpert® MTB/RIF Assay Detection of Mycobacterium tuberculosis in Smear-Negative Individuals with Suspected Tuberculosis.
- Published in:
- Journal of Clinical Medicine, 2017, v. 6, n. 8, p. 78, doi. 10.3390/jcm6080078
- By:
- Publication type:
- Article
Risk Factor Analyses for Immune Reconstitution Inflammatory Syndrome in a Randomized Study of Early vs. Deferred ART during an Opportunistic Infection.
- Published in:
- PLoS ONE, 2010, v. 5, n. 7, p. 1, doi. 10.1371/journal.pone.0011416
- By:
- Publication type:
- Article
Early Antiretroviral Therapy Reduces AIDS Progression/Death in Individuals with Acute Opportunistic Infections: A Multicenter Randomized Strategy Trial.
- Published in:
- PLoS ONE, 2009, v. 4, n. 5, p. 1, doi. 10.1371/journal.pone.0005575
- By:
- Publication type:
- Article
Persistent HIV-infected cells in cerebrospinal fluid are associated with poorer neurocognitive performance.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Diverse Human Immunodeficiency Virus–1 Drug Resistance Profiles at Screening for ACTG A5288: A Study of People Experiencing Virologic Failure on Second-line Antiretroviral Therapy in Resource-limited Settings.
- Published in:
- Clinical Infectious Diseases, 2020, v. 71, n. 7, p. e170, doi. 10.1093/cid/ciz1116
- By:
- Publication type:
- Article
Relationship Between Weight, Efavirenz Exposure, and Virologic Suppression in HIV-Infected Patients on Rifampin-Based Tuberculosis Treatment in the AIDS Clinical Trials Group A5221 STRIDE Study.
- Published in:
- Clinical Infectious Diseases, 2013, v. 57, n. 4, p. 586
- By:
- Publication type:
- Article
Levels of HIV-1 persistence on antiretroviral therapy are not associated with markers of inflammation or activation.
- Published in:
- PLoS Pathogens, 2017, v. 13, n. 4, p. 1, doi. 10.1371/journal.ppat.1006285
- By:
- Publication type:
- Article
Higher Dose Oral Fluconazole for the Treatment of AIDS-related Cryptococcal Meningitis (HIFLAC)—report of A5225, a multicentre, phase I/II, two-stage, dose-finding, safety, tolerability and efficacy randomised, amphotericin B-controlled trial of the AIDS Clinical Trials Group
- Published in:
- PLoS ONE, 2023, v. 17, n. 2, p. 1, doi. 10.1371/journal.pone.0281580
- By:
- Publication type:
- Article
Reply to Bottanelli et al.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Association of Male Sex and Obesity With Residual Plasma Human Immunodeficiency Virus 1 Viremia in Persons on Long-Term Antiretroviral Therapy.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Long-term Outcomes in a Large Randomized Trial of HIV-1 Salvage Therapy: 96-Week Results of AIDS Clinical Trials Group A5241 (OPTIONS).
- Published in:
- 2020
- By:
- Publication type:
- journal article
Cumulative Antiretroviral Exposure Measured in Hair Is Not Associated With Measures of HIV Persistence or Inflammation Among Individuals on Suppressive ART.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Nevirapine- Versus Lopinavir/Ritonavir-Based Initial Therapy for HIV-1 Infection among Women in Africa: A Randomized Trial.
- Published in:
- PLoS Medicine, 2012, v. 9, n. 6, p. 1, doi. 10.1371/journal.pmed.1001236
- By:
- Publication type:
- Article